German Espino L, J Blood Disord Transfus 2016, 7:5(Suppl) conferenceseries.com http://dx.doi.org/10.4172/2155-9864.C1.019 6th International Conference on Hematology October 03-05, 2016 Orlando, USA How we approach chronic myeloid leukemia in a teaching hospital with limited resources in the tyrosine kinase era: Results of the first hundred patients treated with tyrosine kinase inhibitors German Espino L Caja del Seguro Social, Panama lthough Panama is the strongest economy nowadays in the Central America Region, it is difficult to find resources for diagnostic Apurposes or treatment. In the era of the tyrosine kinase inhibitors we know that patients live longer, but this represents a high economical burden for an Institution with limited resources. In the following paper we present the results of the first 100 patients treated for chronic myeloid leukemia in chronic phase. The patients included are those that started treatment after the first tyrosine kinase inhibitor was approved for use in our institution. We will present our diagnostic approach and our follow up together with the limitations that we have had during this period. Biography German Espino L has completed his training in Internal Medicine, Hematology and Stem Cell Transplantation from Hospital Santo Tomas, Caja del Seguro Social and as a Visiting Physician at the Fred Hutchinson Cancer Research Center. He works as a Consultant in Hematology/Stem Cell Transplantation at the Caja del Seguro Social Hospital and as a Professor of Hematology at the University of Panama. He has collaborated as a coauthor in 5 different papers in reputed journals. [email protected] Notes: J Blood Disord Transfus Hematology 2016 Volume 7, Issue 5(Suppl) ISSN: 2155-9864 JBDT, an open access journal October 03-05, 2016 Page 29.